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Objectives: To establish the value of the main pulmonary artery (MPA) diameter assessed 
from unenhanced computer tomography (CT) scans used for attenuation correction (AC) of 
single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) to 
predict pulmonary hypertension (PHT). 
Background: In contrast-enhanced chest CT scans an MPA diameter of 29 mm or greater 
is an established predictor of PHT. However, it is unknown, whether measurements from an 
unenhanced CT scan for AC may be used as predictor of PHT. 
Methods: 100 patients underwent SPECT MPI for assessment of coronary artery disease. 
PHT was defined as a right ventriculo-atrial gradient of 30 mm Hg or greater by Doppler 
echocardiography. We compared MPA diameter from CT to SPECT findings (right ventricular 
hypertrophy/enlargement, septal wall motion abnormality/perfusion defect, and D-shape) to 
determine the best predictor of PHT. 
Results: PHT was found in 37 patients. An MPA diameter of 30 mm or greater yielded a 
sensitivity, specificity, accuracy, positive, and negative predictive value of 78%, 91%, 86%, 
83%, and 88%, respectively. This yielded an area under the ROC curve of 0.85. 
Conclusions: MPA diameter from low-dose unenhanced multi-slice CT reliably predicts 
PHT, providing an important added clinical value from AC for SPECT MPI.  
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INTRODUCTION 
Pulmonary hypertension (PHT) is an important predictor of an adverse outcome in patients with 
known or suspected coronary artery disease1. Several findings of PHT have been reported in nuclear 
single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), such as 
flattening of the interventricular septum (D-shaped left ventricle), septal wall motion 
abnormalities/perfusion defect, and right ventricular (RV) enlargement or hypertrophy2,3. Attenuation 
correction (AC) of MPI with x-ray-derived attenuation maps obtained from a single-slice computer 
tomography scanner (CT) device has been introduced in the last years4. However, transmission scans 
from single-slice CT scanners do not allow reliable interpretation of anatomic details. Recently, use of a 
high-end standalone CTscanner has been proposed to obtain AC maps for MPI5. These low-dose data 
sets from a 64-slice scanner yield an image quality allowing anatomic evaluation.  
While contrast-enhanced chest CT scans provide reliable signs of PHT such as enlarged main 
pulmonary artery (MPA) diameter6, expanded RV outflow tract, and augmented distensibility of the 
MPA7, as well as increased ratio of MPA to aortic diameter8, the accuracy of unenhanced low-dose CT to 
reliably detect PHT from MPA diameter is not yet well validated. 
The aim of this study was to identify the cut-off MPA diameter best predicting PHT from low-
dose unenhanced multi-slice CT for AC of MPI. 
 
MATERIALS AND METHODS 
Patients 
We retrospectively screened 183 consecutive patients referred for coronary artery disease 
assessment with SPECT MPI, until 100 patients were enrolled. To compare our results with the clinical 
gold standard for PHT and to have a study population with a high prevalence of PHT we applied the 
following inclusion criteria: first, transthoracic echocardiography within 6 months from SPECT MPI, 
documenting the right ventriculo-atrial (RV/RA) gradient in mm Hg. Second, a known or suspected 
pulmonary pathology such as bronchial carcinoma, dyspnea, PHT, chronic pulmonary embolism, chronic 
obstructive pulmonary disease, or emphysema. 
The study protocol was approved by the institutional review board and written informed 
consent was obtained. 
 
SPECT MPI Acquisition 
SPECT MPI data acquisition was performed on a dualhead detector camera (Ventri, GE 
Healthcare), using a 1-day stress (0.14 mg/kg/min adenosine i.v. over 6 minutes, or dobutamine 10-40 
lg/kg/min)/rest protocol with a dose of approximately 300 and 900 MBq of 99mTc tetrofosmin, 
respectively, as previously reported9. In brief, we acquired at 3⁰ rotation per stop, 180⁰ each head, and 
25 s per projection, with 16 frames per R-R cycle, according to the procedural guidelines of the 
European Association of Nuclear in Medicine10. For all patients, the summed nongated SPECT image set 
was reconstructed on a dedicated workstation (eNTEGRA or Xeleris; GE Healthcare). In addition, polar 
maps of wall motion (Figure 1) and perfusion (Figure 2) were produced using a commercially available 
software solution (Cedars QGS/QPS; Cedars-Sinai Medical Centre)11. 
 
SPECT MPI Interpretation 
SPECT MPI interpretation was visually performed by two nuclear cardiologists, who were 
blinded to the result from echocardiography and to the CT data. For each patient the long and short-axis 
slices were visually analyzed for two findings: flattening of the interventricular septum (D-shaped left 
ventricle) and RV-enlargement appearing as large as or greater than the left ventricle. In addition, a 
quantitative analysis for RV hypertrophy was performed, using the peak pixel count of the RV and LV in 
the original filtered back projection SPECT rest images, to determine the RV/LV ratio as previously 
reported12. A ratio greater than 0.42 was regarded positive for RV hypertrophy according to results in 
humans by Williams et al3, based on experimental animal data by Wackers et al13. For quantitative 
assessment of septal wall motion (Figure 1B) and perfusion (Figure 2B) abnormality the respective 
QGS/QPS scores of the six septal segments were summed. 
 
CT Scanning 
All CT scans for AC were performed on a 64-slice CT on a LightSpeed VCT XT scanner (GE 
Healthcare) using prospective ECG-triggering (70% of the R-R interval) and the following scanning 
parameters: gantry rotation time 350 ms, 2.5 mm section thickness, 120 kV tube voltage, 200 mA 
effective tube current, resulting in an estimated mean applied radiation dose of 1.1 ± 0.1 mSv (range 
0.9-1.4 mSv)14. Scanning was performed from the tracheal bifurcation to the diaphragm, in inspiration 
and with elevated arms. CT images were reconstructed at 2.5-mm slice thickness using a reconstruction 
algorithm with a 512 9 512 matrix. Reconstructed images were transferred to the external workstation 
for further analysis (AW 4.4, GE Healthcare). 
 
CT Image Analysis 
Two experienced radiologists, who were blinded to the results from echocardiography and the 
SPECT data, assessed the maximumMPA diameter as follows: on standard axial sections in a soft tissue 
window (window widthW400/level L40 Hounsfield units) the widest diameter perpendicular to the long 
axis of the MPA was measured with an electronic caliper (Figure 3). MPA diameter was divided by the 
calculated body surface area (√(weight (kg) x height (cm))/60) to obtain indexed values. 
Echocardiography 
A two-dimensional transthoracic examination was performed in daily routine. The endsystolic 
tricuspid regurgitation jet velocity was used to determine the right ventriculo-atrial (RV/RA) gradient. 
PHT was defined as a value of 30 mm Hg or greater, according to clinical standards. A RV/RA gradient 
between 30 and 39 mm Hg was classified as mild PHT, a gradient between 40 and 59 mm Hg as a 
moderate PHT and a value of 60 mm Hg or greater as severe PHT15. 
 
Statistical Analysis 
The optimal cut-off point for predicting PHT was determined using a receiver operator 
characteristic (ROC) curve for the MPA diameter and the body surface corrected MPA diameter from 
unenhanced CT, for the regional scores for septal stress perfusion defects as well as for the septal wall 
motion abnormalities. For the visually analyzed MPI SPECT signs such as D-shape and RV enlargement 
sensitivity, specificity, positive, and negative predictive values were calculated. 
In addition, all five SPECT MPI criteria for PHT (septal stress perfusion defects/wall motion 
abnormalities, RV hypertrophy/enlargement and D-shape) and the MPA diameter were added up to a 
total score (0-6). ROC analysis was performed for these summed criteria. The optimal cut-off point for all 
ROC curves was determined using the Youden index (J value), calculated as the maximum of J = SN + SP - 
1, where SN is sensitivity and SP is specificity, for each cut-off volume16. Areas under the ROC curve 
(AUC) were calculated and statistically compared with the Delong Delong Clarke-Pearson method17 using 
STATA software (STATA 10.1, Texas, USA). 
Pearson’s correlation coefficient and Bland-Altman analysis were used to determine the inter-
observer agreement of the measured MPA diameter. A P value of < 0.05 was considered to indicate 
statistical significance. Additional Bonferroni correction was performed, where appropriate. The inter-
observer agreement of the visual analysis for D-shaped left ventricular deformation and enlarged right 
ventricle as well as for the measured MPA diameter was determined by kappa coefficient, with a k value 
of 0.2-0.4 indicating a fair agreement, 0.41-0.6 a moderate agreement, 0.61-0.8 a substantial 
agreement, and 0.81-1.00 an almost perfect agreement, according to Landis and Koch12. SPSS software 
(version 18.0, SPSS inc.) was used for statistical testing. 
 
RESULTS 
Patient Characteristics 
Patient characteristics are listed in Table 1. From 100 enrolled patients with suspected or known 
pulmonary pathologies, 60 were referred for preoperative coronary artery disease assessment and in 40 
patients the main reason for cardiac SPECT MPI was dyspnea. For further clinical information see Table 
2. In 72 patients stress examination was performed with 0.14 mg/kg/min adenosine i.v. without any 
complications. In 28 patients dobutamine stress was performed, due to known severe COPD.  
In 2 patients a systemic lupus erythematosus was present, but none of them had an aneurysmal 
pulmonary artery. In 2 patients a a1-antitrypsin deficiency was known, one had no PHT, the second 
patient had a mild PHT (36 mm Hg pressure gradient) with moderate MPA dilatation of 32 mm. 
 
CT and MPI Results 
AUC for MPA diameter as predictor of PHT was 0.85 (with a 95% confidence interval 0.724-
0.923, P <.001) with a resulting cut-off value of 30 mm using the Youden-Index, which yielded a 
sensitivity, specificity, positive (PPV), and negative predictive value (NPV) and accuracy of 78%, 91%, 
83%, 88%, and 86%, respectively. Correction of the MPA diameter for the calculated body surface area 
resulted in a slight decrease of the AUC (0.82), with a cut-off at 1.6 cm/m2, therefore the uncorrected 
diameter was used for further analysis. Uncorrected MPA diameter cut-off at 30 mm with an AUC of 
0.85 proved superior to semiquantitative scores for septal stress perfusion (AUC 0.61, P < .0002), wall 
motion abnormality (P < .0001) and RV hypertrophy (P = .037), although comparison of the latter versus 
MPA diameter fall short of statistical significance after correction according to Bonferroni (Figure 4). 
The combined score of all 6 PHT signs (SPECT and CT) resulted in an AUC of 0.85 (0.77-0.93, 
P<.001) with a cut-off at 2 positive criteria, which yielded a sensitivity, specificity, PPV, NPV, and 
accuracy of 86%, 74%, 67%, 90%, and 79%, respectively (Figure 4B). Thus, the AUC for the combination 
of SPECT and CT criteria was comparable to MPA diameter alone (0.85). However, specificity and 
accuracy were superior for MPA diameter alone (Table 3). 
In 8 patients with documented mild PHT (RV/RA gradient between 30 and 39 mm Hg) MPA 
diameter was smaller than 3 cm classifying these as false negatives. No false negative results were found 
in patients with moderate or severe PHT. Only 6 patients had an RV/RA gradient over 60 mm Hg, 
indicating a severe PHT. The relationship between MPA diameter and PHT is not linear, as it flattens off 
at higher RV/RA gradients (Figure 5). Therefore, a reliable cut-off value to distinguish severe from non-
severe PHT cannot be obtained. 
The visual appreciation of the short- and long-axis SPECT MPI images of observer one resulted in 
47 patients (38 patients for observer two) with a D-shaped left ventricular deformation. There was a 
moderate interobserver correlation with a kappa value of 0.533. 28 of the patients with diagnosed D-
shape by observer one had a pulmonary hypertension; this resulted in a sensitivity, specificity, positive, 
and negative predictive value of 76%, 70%, 60%, and 83%, respectively. Relative RV enlargement was 
found only in 19 patients by observer one and in 25 patients by observer two, what conferred in a poor 
sensitivity (37%) but high specificity (92%) of observer one, with a positive and negative predictive value 
of 73% and 71%, respectively, and a slightly higher sensitivity (38%) but lower specificity (82%) by 
observer two. The inter-observer agreement was fair with a kappa value of 0.362. An overview of all 
results is given in Table 3. 
Inter-observer analysis of MPA diameter assessment revealed an excellent correlation between 
the two observers (r = 0.94, P\.001) with narrow Bland-Altman limits of agreement (-3.1 to 3.8 mm) 
(Figure 6). This resulted in a 94% agreement of PHT diagnosis. There was no relation between a MPA 
diameter of 30 mm or greater and weight, height or BMI as reflected by the area under the ROC curve 
(AUC) of 0.47, 0.53, and 0.46, respectively. 
Two cases are illustrated in Figures 7 and 8. 
 
DISCUSSION 
Our results suggest that unenhanced CT scans as routinely performed for AC of SPECT MPI can 
be used to reliably predict PHT, since an MPA diameter of 30 mm or greater has a high sensitivity (78%) 
and an excellent specificity (91%), with a high inter-observer agreement (r = 0.94, P<.001). The 
established visual SPECT signs are less accurate, and have a moderate inter-observer agreement (kappa 
= 0.533 for D-shape and 0.362 for left ventricular enlargement). The best SPECT MPI finding is the RV 
hypertrophy, measured with the ratio of the peak pixel count RV:LV, with good specificity (87%) but with 
a poor sensitivity (41%), when using a cut-off at 0.42.  
Combining all five SPECT MPI criteria for PHT (septal perfusion defect, septal wall motion 
abnormality, D-shape, RV enlargement, and RV hypertrophy) with the MPA diameter from CT, yields an 
accuracy of 79% (AUC 0.85) compared to 86% (AUC 0.85) of MPA diameter alone. 
In the only previous study in which MPA was assessed from unenhanced CT images to evaluate 
PHT, a cut-off at 33.2 mm was determined yielding a specificity similar to our study but with a much 
lower sensitivity (58%)18. This was probably due—at least in part—to the fact that their slice thickness 
(10 mm) allowed less accurate measurements of anatomic structures than our CT data with a slice 
thickness of 2.5 mm.  
There is a large body of literature with contrast enhanced CT which has established an MPA 
diameter exceeding 29 mm as predictor of PHT19. This value is slightly below our results, because 
contrast-enhanced CT provides the luminal diameter while in unenhanced CT the distance of the outer 
vessel boundaries are measured. 
The unenhanced CT scan of this study was performed to obtain attenuation maps for the SPECT 
MPI and not primarily for diagnostic purposes. Nevertheless, several reports on incidental findings with 
clinical relevance have stimulated a vivid controversy on whether a systematic readout of unenhanced 
CT for AC is mandatory for medico legal and ethical aspects or deleterious due to low specificity 
generating potentially unnecessary harms and costs of further examinations. It is in this setting that the 
present results are of great potential clinical importance as our MPA cut-off provides an excellent 
specificity combined with a large AUC to predict PHT, a clinically relevant finding with important 
implications for perioperative or long-term patient care directly affecting their outcome. Therefore, 
assessment of MPA diameter from unenhanced CT may be considered as a justifiable added value to 
SPECT MPI. 
It may be perceived as a limitation of this study that echocardiography and CT examinations 
were not performed on the same day, as the pulmonary pressure may be subject to changes over time. 
However, the fact that despite this potential drawback the AUC was large strengthens our results and 
may support that MPA enlargement not only reflects acute increase in pulmonary pressure but also 
represents the result of longterm PHT. In addition, using echocardiography as gold standard for 
assessing PHT may be less accurate than invasive right heart catheterization. However, this corresponds 
to daily clinical routine, on which commonly decision making is based. Therefore, it appears justifiable to 
validate our CT-results against the clinical gold standard echocardiography. 
Our results show that the sensitivity of the MPA diameter to predict PHT is not optimal (78%), 
suggesting that unenhanced attenuation CT should not be recommended as a first line screening tool for 
PHT. Another potential limitation is that the assessment of the RV/LV ratio in this study was assessed by 
use of the average counts in the area with the highest counts, while others have used the maximum 
count per pixel in this region. However, both methods have been shown to provide interchangeable and 
equally reproducible results12. 
Furthermore, the presence of collagen disorders in some of our patients may potentially hamper 
the generalization of our results, because such patients would be prone to early MPA enlargement at 
pulmonary pressures in the upper normal range. However, only in two of our patients a a1-antitrypsin 
deficiency was reported, of whom one was true positive and the other was true negative. 
In addition, the image quality of our stand-alone CTscanner may not necessarily be matched by 
that obtained in Hybrid devices with low end CT scanners. 
Finally, the prevalence of pulmonary hypertension in this study population is higher than in the 
general population referred for SPECT MPI in most centers. However, this selection appears reasonable 
for such a validation study, to include a sufficient number of patients presenting with the tested 
pathology, to avoid an artificially high specificity. This would strengthen our results when applied to low 
prevalence populations. The principle of MPA diameter as a reliable predictor of PHT has been well 
established for contrast-enhanced CT in large patient cohorts. Although this study extends this to 
unenhanced low-dose CT the pilot nature limits its power. Therefore, the finding should be interpreted 
with caution before data from larger studies are available. This is particularly true given that in clinical 
practice the 4% patients misclassified with possible PHT would likely be referred on having further 
testing such as echocardiography. 
CONCLUSION 
The non-contrast-enhanced CT scan can be used to detect PHT, while SPECT MPI parameters are 
less accurate in detecting PHT. Thus, in patients undergoing SPECT MPI with a CT attenuation scan; this 
measurement can be reliably performed and may provide useful information about the potential PHT 
without any additional scans. 
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Figure 1. A 63-year-old man with severe chronic obstructive pneumopathy referred for cardiac risk 
assessment before lung transplantation. Polar plot image of rest wall motion (A), with corresponding 
semiquantitative scores (B). The QGS scores of the six septal segments are adding up to a total score of 
4. 
 
Figure 2. Same patient as in Figure 1. Polar plot image of stress perfusion filtered back projection image 
(A), with corresponding semiquantitative scores (B). The QPS scores of the six septal segments are 
adding up to a total score of 4.  
 Figure 3. Main pulmonary artery (MPA) diameter is measured in standard axial slices in soft tissue 
window by assessing the widest diameter perpendicular to the long axis of the MPA. 
 
 
Figure 4. Receiver operating characteristic (ROC) curves are obtained in (A) for main pulmonary artery 
(MPA) diameter [red, which yields the largest area under the curve (0.85)], and for the semiquantitative 
scores for septal wall motion abnormalities (dark blue), septal stress perfusion defects (blue), and right 
ventricular hypertrophy (light blue). The resulting cut-off for MPA diameter is 30 mm, yielding a 
sensitivity, specificity, positive, negative predictive value, and an accuracy of 78%, 91%, 83%, 88%, and 
86%, respectively. (B) The ROC curve for MPA diameter (red) is compared to the ROC curve for the 
combined SPECT/CT score (green) (including septal stress perfusion defect and wall motion abnormality, 
RV hypertrophy, D-shape and RV enlargement, as well as the MPA diameter). The AUC for the 
combination of SPECT and CT criteria as well as for the MPA alone is identical (0.85), however specificity 
and accuracy are still higher for the MPA diameter. 
 
Figure 5. There was no linear correlation between pulmonary hypertension (represented by the RV/RA 
gradient) and MPA diameter, evidenced by the flattening of the curve for higher pressures. To 
determine a reliable cut-off to distinguish severe from non-severe PHT is in this study population not 
possible. 
 
 
Figure 6. Inter-observer analysis of the main pulmonary artery diameter assessed by the two observers: Pearson 
correlation reveals an excellent correlation (r = 0.94, P\.001) (A), and Bland-Altman analysis narrow limits of 
agreement (mean 0.34 mm, SD 1.8 mm) (B). 
 
 
 
 
 
Figure 7. Same patient as in Figure 1. Echocardiography 2 weeks before SPECT MPI showed an RA/RV gradient of 
75 mm Hg. As in this case, 35% of patients with pulmonary hypertension documented by echocardiography reveal 
an enlarged main pulmonary artery (A) and typical SPECT MPI findings such as D-shaped left ventricle in axial 
short axis slices (B), wall motion abnormalities (C), and perfusion defect in filtered back projection stress 
perfusion (D). 
 
 
 
 
Figure 8. A 66-year-old woman with known chronic obstructive pneumopathy referred for cardiac risk 
assessment before wedge resection. Echocardiography 5 months before SPECT MPI showed an RA/RV 
gradient of 40 mm Hg. As in this case, 43% of patients with pulmonary hypertension have an enlarged 
main pulmonary artery (A) but SPECT MPI signs are not conclusive or negative [short axis slices (B), wall 
motion rest (C), and filtered back projection stress perfusion (D)].  
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